Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CRH Medical Corp (CRHM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2020 8-K Quarterly results
05/12/2020 8-K Quarterly results
05/04/2020 8-K Quarterly results
03/11/2020 8-K Quarterly results
11/07/2019 8-K Quarterly results
Docs: "Conference Call CRH will host a conference call to discuss its results on Friday, November 8, 2019, at 9:00 am ET . To participate in the conference, please dial 1-855-327-6838, or 1-604-235-2082. An audio replay will be available shortly after the call by dialing 1-800-319-6413 or 1-604-638-9010 and entering access code 3741. The replay will be available for two weeks after the call. About CRH Medical Corporation CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical ..."
07/31/2019 8-K Quarterly results
Docs: "Selected Second Quarter 2019 Financial Results : Second Quarter Highlights: Total revenue: $30.5 million Operating income: $4.6 million, 15% operating income margin Adjusted operating EBITDA: $13.3 million, 44% adjusted operating EBITDA margin Net and comprehensive income – Shareholder: $1.6 million Adjusted operating EBITDA - Shareholder: $9.7 million Net cash provided by operating activities: $9.6 million Anesthesia patient cases: 84,656 Dr. Tushar Ramani, Chief Executive Officer of CRH commented, "Our 2019 Q2 results show solid revenue and corresponding EBITDA growth, reflecting the hard work of our entire team at CRH. Further, we are pleased to report shareholder level EBITDA of $9.7 million for the quarter." Dr. Ramani added, "Executing on current initiatives, CRH is poised to further..."
05/01/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Rule 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 1, 2019 CRH MEDICAL CORPORATION British Columbia, Canada 001-37542 Not Applicable Suite 578 - 999 Canada Place, World Trade Center, Vancouver, British Columbia, Canada V6C 3E1 633-1440 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) &#97...",
"CRH Medical Corporation Announces 2019 First Quarter Results Total Revenue Grows 18% Compared to Q1 2018"
03/13/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Rule 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 13, 2019 CRH MEDICAL CORPORATION British Columbia, Canada 001-37542 Not Applicable Suite 578 - 999 Canada Place, World Trade Center, Vancouver, British Columbia, Canada V6C 3E1 633-1440 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) &...",
"CRH Medical Corporation Announces 2018 Fourth Quarter and Year-end Results Total Revenue Grows 19% Compared to 2017 VANCOUVER, B.C. - March 13, 2019 - CRH Medical Corporation , today announced its financial and operating results for the year and three months ended December 31, 2018. Selected Fourth Quarter and Full Year 2018 Financial Results:"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy